New!



Retatrutide – Advanced Weight Management
£ 299.00
| Formulation | 10 mg/ml, 3 ml vial, 30 mg total |
| Typical Dose | Personalised following clinical assessment and clinician approval. |
| How to Use | Instructions are provided by the clinician and dispensing partner where access is approved. |
| Vial Supply | Supply depends on the personalised pathway and approved plan. |
| Recommended Course | Duration and review points are agreed with the clinician according to individual suitability and goals. |
| Supports (Pathways) | Appetite and weight management goals |
| Supports (Appetite) | Metabolic health assessment |
| Supports (Blood Sugar) | Body composition planning |
| Supports (Energy Burn) | Ongoing clinician review |
| Supports (Clinical Data) | Ongoing clinician review |
| Audience Target | Adults who want to explore a more structured approach to weight management and metabolic health through a clinical consultation. |
A clinician-guided pathway for next-generation metabolic and weight management support.
How it works?
Retatrutide is an investigational triple receptor agonist being studied for weight management and metabolic health. It is not approved in many jurisdictions. Access through PHI is subject to clinical assessment, local regulation, product status and clinician approval.
Best For:
Clinician-guided weight management and metabolic health pathways.
You Might also like
Shop The Look